Skip to content

Innovative Approaches in Psychedelics, AI, and Communication: A Multi-Domain Perspective.

Robert B. Kargbo

ACS Medicinal Chemistry Letters March 11, 2025 DOI: 10.1021/acsmedchemlett.5c00114 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Commentary Peer reviewed
Intervention asymmetric phenylethylamine compounds
Key points The highlight describes four patented technologies: sublingual psychedelic delivery systems, asymmetric phenylethylamine compounds, AI-assisted communication positioning, and multi-modal data fusion. The author argues these inventions address drug delivery inefficiencies, mental health treatment gaps, precision communication, and integrated diagnostics, and claims they show potential to improve precision, accessibility, and scalability across healthcare and related fields.

Abstract

Emerging innovations across psychedelics, artificial intelligence (AI), and communication technologies are reshaping healthcare and beyond. This Patent Highlight showcases advancement in sublingual delivery systems for psychedelics, asymmetric phenylethylamine compounds, AI-assisted communication positioning, and multi-modal data fusion, respectively. These inventions address challenges like drug delivery inefficiencies, mental health treatment gaps, precision communication, and integrated diagnostics. Together, they demonstrate the transformative potential of cross-disciplinary technological advancements in enhancing precision, accessibility, and scalability in their respective fields.

Citations in the library